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Abstract 
Background/Aims: Rubella can be devastating to a foetus if maternally 
acquired in early pregnancy. A single rubella vaccine (SRV), given to 
prepubertal girls was replaced by the MMR immunisation in infancy for both 
sexes in 1988. Women born before 1983 probably received the SRV and had 
contact with circulating rubella, whilst women born after 1982 probably received 
the MMR vaccine and had little contact with circulating rubella. When immunity 
levels fall, outbreaks can occur, as seen in the last 10 years. The rubella status 
of antenatal women in the Cwm Taf (South) Health Board area and post-partum 
vaccine uptake in the rubella susceptible women was explored.  
Method: Data of 14,519 antenatal rubella tests (2005-2010) and questionnaire 
data from 111 rubella susceptible women (2009-2011) were analysed. Self-
reported immunisation status and post-partum vaccine uptake were validated by 
examination of childhood immunisation records and medical records. Data for 
probable SRV recipients and probable MMR vaccine recipients were compared.  
Key Results: The overall rubella susceptibility rate increased from 3.8% 
(88/2312) in 2005 to 4.6% (116/2536) in 2010. First pregnancy data showed a 
statistically significant increase in susceptibility from 6.4% (49/760) in 2005 to 
8.9% (71/798) in 2010 (²=6.860, df=1, p=0.009) and women born after 1982 
were five times more likely to be rubella susceptible than those born earlier 
(odds ratio=5.05, 95% CI from 3.46 to 7.35). Those aged < 20 years had a 
mean susceptibility rate of 21.3% (236/1107) Average antibody titres for rubella 
immune women differed significantly by year of birth; those born earlier had a 
stable average of 58 IU/ml whilst those born later (following a period of steady 
decline) averaged 20 IU/ml. Of rubella susceptible women in the questionnaire 
study, 62.8% had received two or more doses of a rubella containing vaccine. 
Examination of medical records showed that over 36% (39/107) of rubella 
susceptible women in the study did not receive post-partum immunisation.  
Conclusion: The results suggest that immunity is waning, and that a third dose 
of MMR vaccine in adolescence is required to ensure protection during 
pregnancy. The study also demonstrates that reliance on Child Health Records 
to assess need for immunisation is flawed. Post-partum MMR uptake also 
needs to be addressed if national targets are to be met.  
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Overview 
 
The Origins of this Study 
 
This study arose out of my perception from laboratory practice, in the 
virology laboratory at the Royal Glamorgan Hospital (Cwm Taf Health Board) in 
South Wales, that the percentage of pregnant women who were rubella 
susceptible was increasing. Part of my substantive role was to supervise rubella 
antibody testing and to authorise the results. There seemed to be an increase in 
the number of samples with a rubella IgG antibody level of <10 IU/ml collected 
during antenatal screening. I decided to establish if this perception was 
supported by evidence and, if so, to explore the reasons why. The study was 
undertaken as part of a Professional Doctorate in Biomedical Sciences at the 
University of the West of England, Bristol. 
The taught doctorate sessions guided the selection of data collection 
methods, the questionnaire design and the subsequent analysis. I was 
personally responsible for the ethical approval applications, collecting the data 
from booking blood forms, developing the questionnaire, extracting the relevant 
data and performing the appropriate analyses. 
The results of this work have been disseminated in the form of seven oral 
presentations and six poster presentations at local, national and international 
events. Two journal publications were produced from data collected in this 
study. The first (Matthews et al, 2010) discussed the rubella susceptibility rates 
in the study area and subsequently has been cited in four other publications to 
date. The second (Matthews et al, 2013) discusses the uptake of post partum 
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MMR in the study area. A third paper entitled “Is vaccine induced rubella 
immunity waning in areas with no circulating rubella? A study of antenatal 
women in a South Wales Health Board” is ready for submission for publication 
to a relevant journal. I was the primary author in the preparation of all three 
papers, whilst the various co-authors had input into the final documents. 
Therefore this study has contributed to the knowledge of rubella status in 
pregnant women in the early 21st Century. Information from the first published 
paper, documenting rubella susceptibility rates from early data produced by this 
study (Matthews et al, 2010), was used (along with other information) in 
discussions about policy change (Tookey, P.A. 2012; Department of Health, 
2011). In the Cwm Taf study the rubella susceptible women had their 
immunisation status checked against Child Health records, which also produced 
new data that have implications for the proposed changes in antenatal 
screening. The most important finding in this study arises from the examination 
of rubella IgG antibody levels in those pregnant women who are classed as 
immune. These data demonstrate waning immunity in the absence of circulating 
rubella, which has long term implications. These data will have implications for 
future decisions of the Joint Committee on Vaccination and Immunisation.  
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Trust Changes 
 
Please note that during the period of the study: 
 
 Llwynypia hospital closed and services were transferred to the new 
Ysbyty Cwm Rhondda. 
 Pontypridd and Rhondda NHS Trust merged with North Glamorgan Trust 
to become Cwm Taf NHS Trust north and south. 
 Cwm Taf NHS Trust became Cwm Taf Local Health board using the 
operating name of Cwm Taf Health Board 
 The National Public Health Service (Wales) (NPHS) was renamed Public 
Health Wales (PHW)  
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